Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rebecca Arend, M.D.
University of Alabama at Birmingham
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Womens & Infants Center
Birmingham, Alabama, United States
Recruiting - University of California San Francisco
San Francisco, California, United States
Recruiting - University of Minnesota - Masonic Cancer Center
Minneapolis, Minnesota, United States
Recruiting - Mayo Clinic
Rochester, Minnesota, United States
Recruiting - University of Mississippi Medical Center
Oxford, Mississippi, United States
Recruiting - Ohio State University
Columbus, Ohio, United States
Recruiting - University of Oklahoma
Oklahoma City, Oklahoma, United States
Recruiting - Allegheny Health Network
Pittsburgh, Pennsylvania, United States
Recruiting - University of Virginia
Richmond, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 May 2021
- Primary completion
- 31 May 2026
- Completion
- 31 May 2028
- Last update posted
- 8 Sept 2025
- Registered enrollment
- 70
- Registry id
- NCT04606914
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.